Ivosidenib
| Use attributes for filter ! | |
| ATC code | L01XX62 (WHO) |
|---|---|
| Trade name | Tibsovo |
| Drug class | Antineoplastic Agents |
| License data | DailyMed |
| US | |
| FDA | |
| Route | Oral administration |
| Routes of administration | Oral |
| Music groups | Enasidenib |
| Gilteritinib | |
| Glasdegib | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951276 |
About Ivosidenib
Ivosidenib is an experimental drug for treatment of cancer. It is a small molecule inhibitor of isocitrate dehydrogenase-1, which is mutated in several forms of cancer. The drug is being developed by Agios Pharmaceuticals and is in phase III clinical trials.